1. According to research from Dandelion Health, a phase 3 trial showed that Wegovy reduced major adverse cardiovascular events by 20% and cut down on heart failure-related symptoms among overweight or obese patients with preexisting severe cardiovascular disease.
2. Machine-learning models may be used to bolster the American Heart Association’s cardiovascular disease risk equations, according to a Sept. 18 study published in JAMA Cardiology.
3. Genetic testing can be used to measure an individual’s stress-related heart attack risk, according to research presented by Somerville, Mass.-based Mass General Brigham at the American College of Cardiology’s annual meeting.
4. According to a study presented at the American Heart Association’s 2024 Hypertension Scientific Session, a combination of remote monitoring and pharmacist support improved blood pressure in 74% of patients whose blood pressure was previously resistant to treatment.
5. According to a study published in JACC: Cardiovascular Imaging, approximately 44.2 million people in the U.S live more than 60 miles away from the nearest cardiac positron emission tomography center.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
